Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 2012; Volume 82,Issue 5

Minireview

  • You have access
    Adhesion G Protein-Coupled Receptors: Signaling, Pharmacology, and Mechanisms of Activation
    Kevin J. Paavola and Randy A. Hall
    Molecular Pharmacology November 2012, 82 (5) 777-783; DOI: https://doi.org/10.1124/mol.112.080309

Articles

  • You have access
    Cysteine Residues in the Transmembrane (TM) 9 to TM11 Region of the Human Equilibrative Nucleoside Transporter Subtype 1 Play an Important Role in Inhibitor Binding and Translocation Function
    Jamie S. Park and James R. Hammond
    Molecular Pharmacology November 2012, 82 (5) 784-794; DOI: https://doi.org/10.1124/mol.112.079616
  • You have access
    Structure-Activity Relationship of Fenamates as Slo2.1 Channel Activators
    Priyanka Garg and Michael C. Sanguinetti
    Molecular Pharmacology November 2012, 82 (5) 795-802; DOI: https://doi.org/10.1124/mol.112.079194
  • You have access
    Molecular Mechanisms of Chloroquine Inhibition of Heterologously Expressed Kir6.2/SUR2A Channels
    Daniela Ponce-Balbuena, Aldo A. Rodríguez-Menchaca, Angélica López-Izquierdo, Tania Ferrer, Harley T. Kurata, Colin G. Nichols and José A. Sánchez-Chapula
    Molecular Pharmacology November 2012, 82 (5) 803-813; DOI: https://doi.org/10.1124/mol.112.079152
  • You have access
    P6981, An Arylstibonic Acid, Is a Novel Low Nanomolar Inhibitor of cAMP Response Element-Binding Protein Binding to DNA
    Jianfei Zhao, Jason R. Stagno, Lyuba Varticovski, Eric Nimako, Vikas Rishi, Kathy McKinnon, Rhone Akee, Robert H. Shoemaker, Xinhua Ji and Charles Vinson
    Molecular Pharmacology November 2012, 82 (5) 814-823; DOI: https://doi.org/10.1124/mol.112.080820
  • You have access
    In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine
    Natalia Mast, Marlin Linger, Matthew Clark, Jeffrey Wiseman, C. David Stout and Irina A. Pikuleva
    Molecular Pharmacology November 2012, 82 (5) 824-834; DOI: https://doi.org/10.1124/mol.112.080424
  • You have access
    Cytochrome P450 Architecture and Cysteine Nucleophile Placement Impact Raloxifene-Mediated Mechanism-Based Inactivation
    Brooke M. VandenBrink, John A. Davis, Josh T. Pearson, Robert S. Foti, Larry C. Wienkers and Dan A. Rock
    Molecular Pharmacology November 2012, 82 (5) 835-842; DOI: https://doi.org/10.1124/mol.112.080739
  • You have access
    Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 Receptor
    Daniel C.-H. Lin, Qi Guo, Jian Luo, Jane Zhang, Kathy Nguyen, Michael Chen, Thanh Tran, Paul J. Dransfield, Sean P. Brown, Jonathan Houze, Marc Vimolratana, Xian Yun Jiao, Yingcai Wang, Nigel J. M. Birdsall and Gayathri Swaminath
    Molecular Pharmacology November 2012, 82 (5) 843-859; DOI: https://doi.org/10.1124/mol.112.079640
  • You have access
    Investigating Metabotropic Glutamate Receptor 5 Allosteric Modulator Cooperativity, Affinity, and Agonism: Enriching Structure-Function Studies and Structure-Activity Relationships
    Karen J. Gregory, Meredith J. Noetzel, Jerri M. Rook, Paige N. Vinson, Shaun R. Stauffer, Alice L. Rodriguez, Kyle A. Emmitte, Ya Zhou, Aspen C. Chun, Andrew S. Felts, Brian A. Chauder, Craig W. Lindsley, Colleen M. Niswender and P. Jeffrey Conn
    Molecular Pharmacology November 2012, 82 (5) 860-875; DOI: https://doi.org/10.1124/mol.112.080531
  • You have access
    Chaperone Heat Shock Protein 90 Mobilization and Hydralazine Cytoprotection against Acrolein-Induced Carbonyl Stress
    Philip C. Burcham, Albert Raso and Lisa M. Kaminskas
    Molecular Pharmacology November 2012, 82 (5) 876-886; DOI: https://doi.org/10.1124/mol.112.078956
  • You have access
    Redox Regulation by Nuclear Factor Erythroid 2-Related Factor 2: Gatekeeping for the Basal and Diabetes-Induced Expression of Thioredoxin-Interacting Protein
    Xiaoqing He and Qiang Ma
    Molecular Pharmacology November 2012, 82 (5) 887-897; DOI: https://doi.org/10.1124/mol.112.081133
  • You have access
    A Second Extracellular Site Is Required for Norepinephrine Transport by the Human Norepinephrine Transporter
    Ching-I A. Wang, Nausad H. Shaikh, Soumya Ramu and Richard J. Lewis
    Molecular Pharmacology November 2012, 82 (5) 898-909; DOI: https://doi.org/10.1124/mol.112.080630
  • You have access
    Activation of α7 Nicotinic Receptors by Orthosteric and Allosteric Agonists: Influence on Single-Channel Kinetics and Conductance
    Magda M. Pałczyńska, Marie Jindrichova, Alasdair J. Gibb and Neil S. Millar
    Molecular Pharmacology November 2012, 82 (5) 910-917; DOI: https://doi.org/10.1124/mol.112.080259
  • You have access
    The Orphan Nuclear Receptor DAX-1 Functions as a Potent Corepressor of the Constitutive Androstane Receptor (NR1I3)
    Elizabeth M. Laurenzana, Tao Chen, Malavika Kannuswamy, Brian E. Sell, Stephen C. Strom, Yong Li and Curtis J. Omiecinski
    Molecular Pharmacology November 2012, 82 (5) 918-928; DOI: https://doi.org/10.1124/mol.112.080721
  • You have access
    Pharmacological Characterization and Modeling of the Binding Sites of Novel 1,3-Bis(pyridinylethynyl)benzenes as Metabotropic Glutamate Receptor 5-Selective Negative Allosteric Modulators
    Christina Mølck, Kasper Harpsøe, David E. Gloriam, Rasmus P. Clausen, Ulf Madsen, Lars Ø. Pedersen, Hermogenes N. Jimenez, Søren M. Nielsen, Jesper M. Mathiesen and Hans Bräuner-Osborne
    Molecular Pharmacology November 2012, 82 (5) 929-937; DOI: https://doi.org/10.1124/mol.112.078808
  • You have access
    Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates Oncomirs
    Wenchang Guo, Ruiwu Liu, Yoko Ono, Ai-Hong Ma, Anthony Martinez, Eduardo Sanchez, Yan Wang, Wenzhe Huang, Anisha Mazloom, Jixian Li, Jinying Ning, Emanual Maverakis, Kit S. Lam and Hsing-Jien Kung
    Molecular Pharmacology November 2012, 82 (5) 938-947; DOI: https://doi.org/10.1124/mol.112.079889
  • You have access
    Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Induces Astrocyte Proliferation through the Activation of Transforming-Growth Factor-α/Epidermal Growth Factor Receptor Signaling Pathway
    Estelle Rousselet, Sabine Traver, Yann Monnet, Aline Perrin, Nathalie Mandjee, Audrey Hild, Etienne C. Hirsch, Timothy S. Zheng and Stéphane Hunot
    Molecular Pharmacology November 2012, 82 (5) 948-957; DOI: https://doi.org/10.1124/mol.112.079608
  • You have access
    LYG-202 Augments Tumor Necrosis Factor-α-Induced Apoptosis via Attenuating Casein Kinase 2-Dependent Nuclear Factor-κB Pathway in HepG2 Cells
    Fei-hong Chen, Na Lu, Hai-wei Zhang, Li Zhao, Li-cheng He, Hao-peng Sun, Qi-dong You, Zhi-yu Li and Qing-long Guo
    Molecular Pharmacology November 2012, 82 (5) 958-971; DOI: https://doi.org/10.1124/mol.112.079848
  • You have access
    α-Conotoxin PeIA[S9H,V10A,E14N] Potently and Selectively Blocks α6β2β3 versus α6β4 Nicotinic Acetylcholine Receptors
    Arik J. Hone, Mick'l Scadden, Joanna Gajewiak, Sean Christensen, Jon Lindstrom and J. Michael McIntosh
    Molecular Pharmacology November 2012, 82 (5) 972-982; DOI: https://doi.org/10.1124/mol.112.080853
  • You have access
    Morphine Desensitization and Cellular Tolerance Are Distinguished in Rat Locus Ceruleus Neurons
    Erica S. Levitt and John T. Williams
    Molecular Pharmacology November 2012, 82 (5) 983-992; DOI: https://doi.org/10.1124/mol.112.081547
  • You have access
    Coordinated Regulation of Murine Cardiomyocyte Contractility by Nanomolar (−)-Epigallocatechin-3-Gallate, the Major Green Tea Catechin
    Wei Feng, Hyun Seok Hwang, Dmytro O. Kryshtal, Tao Yang, Isela T. Padilla, Asheesh K. Tiwary, Birgit Puschner, Isaac N. Pessah and Björn C. Knollmann
    Molecular Pharmacology November 2012, 82 (5) 993-1000; DOI: https://doi.org/10.1124/mol.112.079707
  • You have access
    Critical Role for Mixed-Lineage Kinase 3 in Acetaminophen-Induced Hepatotoxicity
    Manju Sharma, Vidya Gadang and Anja Jaeschke
    Molecular Pharmacology November 2012, 82 (5) 1001-1007; DOI: https://doi.org/10.1124/mol.112.079863
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 82 (5)
Molecular Pharmacology
Vol. 82, Issue 5
1 Nov 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics